Answers are grounded in this paper and cite their sources.
Heterocyclic hydrazides and hydrazones are versatile chemotypes with tunable electronic, conformational, hydrogen-bonding, and metal-coordinating properties. This review summarizes recent synthetic routes to heterocyclic hydrazides and their transformation into hydrazones, azoles, fused heterocycles, molecular hybrids, and metal complexes. Their antimicrobial, antiviral, anticancer, analgesic, anti-inflammatory, neuroprotective, and plant growth regulatory activities are discussed in relation to structure and mechanism. Reported derivatives act through enzyme and kinase inhibition, disruption of microtubule dynamics, induction of cell-cycle arrest and apoptosis, modulation of neurotransmission, attenuation of oxidative stress, and controlled drug release. Biological activity is governed by the complete molecular architecture, including heterocycle identity, substituent electronics, lipophilicity, conformational flexibility, E/Z isomerism, tautomerism, and hydrolytic stability. Further development requires stronger target validation, pharmacokinetic and toxicological profiling, and evaluation in relevant in vivo models. Integrating rational synthesis with structure–activity relationship analysis may support the development of selective hydrazide-based therapeutic candidates.
No takes yet. Share an insight, caveat, or question.
Kazhdenbek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: